ReiThera

ReiThera Srl is a company dedicated to the development and production of biopharmaceutical products based on gene delivery technology for advanced therapies to prevent and treat a variety of severe or life-threatening diseases. ReiThera's management and scientific team has successfully developed genetic vaccines for major infectious diseases, including hepatitis C, malaria, HIV, respiratory syncytial virus, and Ebola virus, using the highly innovative chimpanzee-derived adenovirus (ChAd) platform within Okairos. In addition to this platform, ReiThera also possesses unique expertise in large-scale GMP gene vaccine manufacturing. The GMP manufacturing facility meets the strictest standards for materials used in human clinical research.